Vaccinex, Inc. financial statements
Vaccinex, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2024
| Revenue | USD 601K | 10-K |
| Net income | −USD 18.63M | 10-K |
| Cash and equivalents | USD 1.11M | 10-K |
| Total debt | USD 25K | 10-K |